body
Increased Photosensitivity
Adverse effectIncreased Photosensitivity is an adverse body effect involving an unusually strong skin reaction to light, described as photosensitisation or phototoxicity. It refers to a potential skin response rather than a desired benefit, and does not mean that everyone exposed to a relevant intervention will experience it.
Increased Photosensitivity is categorized as a body effect.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What can cause it
How likely each one is to cause it, most likely first.
Red Light Therapy (Photobiomodulation)practiceUnclear
Based on one study. Strongest study: a pooled analysis of several trials.
A 2025 pooled analysis of randomized trials in people with Age-Related Macular Degeneration (AMD) reported photophobia, or light sensitivity.
Open the Red Light Therapy (Photobiomodulation) page
The expert view shows every study, dose protocol and source.
What can cause it
Interventions reported to bring this on1 listedHighest probability
- →PracticesRed Light Therapy (Photobiomodulation)CertaintyLowSourceClinical1 other source
A 2025 pooled analysis of randomized trials in people with Age-Related Macular Degeneration (AMD) reported photophobia, or light sensitivity.
Who was studied
- People with a condition
- Age Related Macular Degeneration
Open Red Light Therapy (Photobiomodulation)Study result
Photophobia
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Increased Photosensitivity is an adverse body effect involving an unusually strong skin reaction to light, described as photosensitisation or phototoxicity. It refers to a potential skin response rather than a desired benefit, and does not mean that everyone exposed to a relevant intervention will experience it. St. John's Wort and Aloe Vera are examples associated with this effect.
How interventions help
Increased photosensitivity can appear as a tendency for skin to react more strongly to ultraviolet exposure, including easier sunburn or other photosensitive skin reactions. The interventions associated with this outcome include plant-derived products, isolated compounds, and vitamins, but they do not all present the same pattern. Some concerns are linked specifically with high, very high, large, or prolonged doses, while other reports do not define a dose or describe the reaction in enough detail to identify a clear exposure threshold.
The findings use several related descriptions, including photosensitisation, phototoxicity, increased ultraviolet sensitivity, and photosensitive skin lesions. This suggests that the practical concern is not limited to one type of product or one proposed pathway. However, the available descriptions do not establish how quickly sensitivity begins, whether continuous use is required, or whether the effect persists after stopping. Applicability to particular health conditions or skin types is also not specified, so these findings should be interpreted as general reference information rather than a prediction for any individual.
Choosing guidance
When choosing among these options, the main distinction is not the listed likelihood but how directly the concern has been documented. St. John's Wort and Aloe Vera have clinical evidence labels, while the remaining options rely on anecdotal reports or pharmacology references. This makes the clinical entries more relevant for readers who want evidence from clinical use, whereas the other entries should be interpreted more cautiously because reports may be limited or may not have been verified.
The descriptions also suggest that amount can matter. Increased sun sensitivity is associated with high-dose use for Green Tea Extract (EGCG) and Quercetin, higher doses for Resveratrol, very high doses for Vitamin B2 (Riboflavin), and large or prolonged doses for Vitamin B6 (Pyridoxine). Vitamin A is described in relation to retinoids and high-dose use. However, no exact dose thresholds or time-to-onset information are provided, so these options cannot be compared by how quickly the effect might appear or by a specific duration of use.
No health status is specified for the entries, and the evidence does not identify a particular population for whom one option is more suitable. Readers who are especially concerned about sun exposure may prefer to give greater weight to the options with clinical evidence, while treating anecdotal reports and pharmacology-based cautions as signals of uncertainty rather than confirmed effects. The evidence bases also do not establish that all options carry the same degree of practical concern, even when their listed relationship is similar.